Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients

ConclusionAntibody detection provides important clinical information in the COVID-19 process. The different signatures in Ig isotypes, IgG subclasses, antibody specificity between the COVID-19 severe and non-severe group will contribute to future therapeutic and preventive measures development.Graphical Abstract

http://link.springer.com/10.1186/s40249-022-00940-w

Source: Infectious Diseases of Poverty - February 2, 2022 Category: Infectious Diseases Source Type: research